相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme
Hadeer K. Swedan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
One-pot synthesis of some new regioselective 4β-pyrazolepodophyllotoxins as DNA topoisomerase-II targeting anticancer agents
Rajkumar Nagavath et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties
Xin Zhang et al.
BIOORGANIC CHEMISTRY (2022)
Identification of Novel 4′-O-Demethyl-epipodophyllotoxin Derivatives as Antitumor Agents Targeting Topoisomerase II
Wenli Xi et al.
MOLECULES (2022)
The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives
Karolina Jalbrzykowska et al.
CANCERS (2022)
Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis
Hamada H. H. Mohammed et al.
BIOORGANIC CHEMISTRY (2021)
Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment-The Effect of Dose-Response on 2D and 3D Cell Cultures
Tomasz Kloskowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment
Qiang Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Novel podophyllotoxin and benzothiazole derivative induces transitional morphological and functional changes in HaCaT cells
Piotr Strus et al.
TOXICOLOGY IN VITRO (2021)
Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates
Alicja Chrzanowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Fluoroquinolone antibiotics show genotoxic effect through DNA-binding and oxidative damage
Prabuddha Bhattacharya et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)
Antitumour Anthracyclines: Progress and Perspectives
Maristela B. Martins-Teixeira et al.
CHEMMEDCHEM (2020)
Cyanine dye mediated mitochondrial targeting enhances the anti-cancer activity of small-molecule cargoes
Alexander R. Noedling et al.
CHEMICAL COMMUNICATIONS (2020)
G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner
Lin Yang et al.
CARCINOGENESIS (2019)
Apoptosis Induced by Ultraviolet A Exposure in the Presence of Enoxacin in HL-60 Cells
Haruka Shinada et al.
ANTICANCER RESEARCH (2019)
Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth
Vikas Yadav et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Quinolone hybrids and their anti-cancer activities: An overview
Feng Gao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Moxifloxacin as an inducer of apoptosis in melanoma cells: A study at the cellular and molecular level
Artur Beberok et al.
TOXICOLOGY IN VITRO (2019)
GSH-responsive anti-mitotic cell penetrating peptide-linked podophyllotoxin conjugate for improving water solubility and targeted synergistic drug delivery
Jia Wen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Towards anticancer fluoroquinolones: A review article
Mohamed A. A. Abdel-Aal et al.
ARCHIV DER PHARMAZIE (2019)
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations
Mandeep Atwal et al.
MOLECULAR PHARMACOLOGY (2019)
Design, synthesis, biological evaluation, structure-activity relationship, and toxicity of clinafloxacin-azole conjugates as novel antitubercular agents
Jie Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Click chemistry-based synthesis and cytotoxic activity evaluation of 4α-triazole acetate podophyllotoxin derivatives
Wei Hou et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity
Kommula Dileep et al.
MOLECULAR DIVERSITY (2018)
Topoisomerases as anticancer targets
Justine L. Delgado et al.
BIOCHEMICAL JOURNAL (2018)
Synthesis and biological evaluation of 4β-(thiazol-2-yl)amino-4'-O-demethyl-4-deoxypodophyllotoxins as topoisomerase-II inhibitors
Chun-Yan Sang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity
Asmaa E. Kassab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
4-Quinolone derivatives and their activities against Gram positive pathogens
Gui-Fu Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
4 beta-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-II alpha inhibition and potential anticancer agents for prostate cancer
V. Ganga Reddy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and evaluation of novel 1,3,4-thiadiazole-fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents
Asli Demirci et al.
TURKISH JOURNAL OF CHEMISTRY (2018)
Recent updates of fluoroquinolones as antibacterial agents
Hend A. A. Ezelarab et al.
ARCHIV DER PHARMAZIE (2018)
Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesis
Taylor C. Vracar et al.
SCIENTIFIC REPORTS (2018)
Recent developments in topoisomerase-targeted cancer chemotherapy
Kirk E. Hevener et al.
ACTA PHARMACEUTICA SINICA B (2018)
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
Jessica Marinello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Therapeutic Outlook of Pyrazole Analogs: A Mini Review
Swastika Ganguly et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Synthesis and characterization of N-Mannich based prodrugs of ciprofloxacin and norfloxacin: In vitro anthelmintic and cytotoxic evaluation
Mona Piplani et al.
JOURNAL OF ADVANCED RESEARCH (2017)
Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models
Roman Akasov et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
Enoxacin with UVA Irradiation Induces Apoptosis in the AsPC1 Human Pancreatic Cancer Cell Line Through ROS Generation
Koji Nishi et al.
ANTICANCER RESEARCH (2017)
Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities
Temilolu Idowu et al.
ANTIBIOTICS-BASEL (2017)
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
Hisao Imai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies
Alaa A. -M. Abdel-Aziz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phase
Hamada H. H. Mohammed et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
Gene C. Jamieson et al.
DRUGS (2016)
LZ-106, a novel analog of enoxacin, inducing apoptosis via activation of ROS-dependent DNA damage response in NSCLCs
Lin Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model
Nicole E. Frank et al.
INVESTIGATIONAL NEW DRUGS (2016)
The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity
Abdul Naeem et al.
MOLECULES (2016)
Biologically active γ-lactams: synthesis and natural sources
J. Caruano et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Potential anti-MDR agents based on the podophyllotoxin scaffold: synthesis and antiproliferative activity evaluation against chronic myeloid leukemia cells by activating MAPK signaling pathways
Lei Zhang et al.
RSC ADVANCES (2016)
New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage
Dharmendra K. Yadav et al.
SCIENTIFIC REPORTS (2016)
Activity of Quinolone CP-115,955 Against Bacterial and Human Type II Topoisomerases Is Mediated by Different Interactions
Katie J. Aldred et al.
BIOCHEMISTRY (2015)
Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors
Sarah A. Holstein et al.
INVESTIGATIONAL NEW DRUGS (2015)
The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway
Xuqiang Liu et al.
BIOMATERIALS (2014)
Synthesis, antimycobacterial and antibacterial evaluation of 1-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety
Hongmin Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
A clinical update of using albumin as a drug vehicle - A commentary
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2014)
Doxorubicin Nanoconjugates
Kannan Deepa et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2014)
New azetidine-3-carbonyl-N-methyl-hydrazino derivatives of fluoroquinolones: synthesis and evaluation of antibacterial and anticancer properties
G. Govinda Rajulu et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
Overcoming Target-Mediated Quinolone Resistance in Topoisomerase IV by Introducing Metal-Ion-Independent Drug-Enzyme Interactions
Katie J. Aldred et al.
ACS CHEMICAL BIOLOGY (2013)
A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery
Changli Du et al.
BIOMATERIALS (2013)
Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines
Narva Suresh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Quino lone Derivatives as Potential Antitumor Topoisomerase I Inhibitors
Kai-jun Shou et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2013)
Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity
Mohamed Abdel-Aziz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Topoisomerase as target for antibacterial and anticancer drug discovery
Muthu K. Kathiravan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance
Katie J. Aldred et al.
NUCLEIC ACIDS RESEARCH (2013)
Synthesis of novel 2, 5-dihydrofuran derivatives and evaluation of their anticancer activity
Yikai Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety
Lianshun Feng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis, Anticancer Activities, and Cellular Uptake Studies of Lipophilic Derivatives of Doxorubicin Succinate
Bhupender S. Chhikara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Quinolone compounds enhance δ-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells
Yoshiko Ohgari et al.
JOURNAL OF BIOCHEMISTRY (2011)
Solution structures of DNA-bound gyrase
Nicole M. Baker et al.
NUCLEIC ACIDS RESEARCH (2011)
Synthesis and In Vitro Antibacterial Activity of 7-(3-Alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)fluoroquinolone Derivatives
Yi-Bin Zhang et al.
ARCHIV DER PHARMAZIE (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Voreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A Report on Two Dosing Schedules
Ranjana H. Advani et al.
CLINICAL CANCER RESEARCH (2010)
QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines exhibiting anticancer activity by optimal SMILES-based descriptors
A. A. Toropov et al.
JOURNAL OF MATHEMATICAL CHEMISTRY (2010)
Conformational diversity of anthracycline anticancer antibiotics: A density functional theory calculation
Suhua Zhu et al.
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM (2010)
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Benjamin D. Bax et al.
NATURE (2010)
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
Alexandre Wohlkonig et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles
Fu-Qiang Hu et al.
BIOMATERIALS (2009)
Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin
Gamal El-Din A. A. Abuo-Rahma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases
Ivan Laponogov et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System
Jean-Marc Barret et al.
CANCER RESEARCH (2008)
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
Anna M. Azarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
DNA topoisomerase II structures and anthracycline activity: Insights into ternary complex formation
D. Dal Ben et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Interaction model for anthracycline activity against DNA topoisomerase II
S Moro et al.
BIOCHEMISTRY (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Synthesis, cytotoxicity and antiviral activity of podophyllotoxin analogues modified in the E-ring
MA Castro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide
PE Schroeder et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Catalytic topoisomerase II inhibitors in cancer therapy
AK Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Development of the quinolones
MI Andersson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
In vitro method for prediction of the phototoxic potentials of fluoroquinolones
T Yamamoto et al.
TOXICOLOGY IN VITRO (2001)
DNA topoisomerases as targets for anticancer drugs
Z Topcu
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2001)
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions
C Sissi et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Tumor cell death induced by topoisomerase-targeting drugs
TK Li et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives -: Eleutherin, α lapachone, and β lapachone
P Krishnan et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Synthesis of picropodophyllin homolactone
E Roulland et al.
TETRAHEDRON LETTERS (2000)
F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action
D Perrin et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Engineering the specificity of antibacterial fluoroquinolones:: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase
FL Alovero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Targeting DNA with anthracyclines: The importance of the sugar moiety
W Priebe
MOLECULES (2000)